Organogenesis Holdings (ORGO) Inventory (2017 - 2026)

Organogenesis Holdings' Inventory history runs 10 years deep, the most recent figure standing at $28.4 million for Q1 2026.

• On a quarterly basis, Inventory fell 3.11% year-over-year to $28.4 million in Q1 2026; TTM through Mar 2026 was $28.4 million, a 3.11% decrease from a year earlier, with the FY2025 full-year figure at $29.6 million, up 13.0% from the prior year.
• Inventory retreated to $28.4 million in Q1 2026 per ORGO's latest filing, from $29.6 million in the prior quarter.
• Across five years, Inventory topped out at $39.6 million in Q3 2025 and bottomed at $22.7 million in Q1 2022.
• The 5-year median for Inventory is $27.0 million (2024), against an average of $27.7 million.
• Across the five-year window, Inventory retreated 23.5% in 2022 and soared 46.41% in 2025, its largest moves.
• Year by year, Inventory stood at $24.8 million in 2022, then climbed by 14.0% to $28.3 million in 2023, then dropped by 7.2% to $26.2 million in 2024, then advanced by 13.0% to $29.6 million in 2025, then fell by 4.06% to $28.4 million in 2026.
• Per Business Quant, the three latest ORGO Inventory figures stand at $28.4 million (Q1 2026), $29.6 million (Q4 2025), and $39.6 million (Q3 2025).